Slp3 Activators
Slp3 activators are a diverse array of chemical compounds that facilitate the functional upregulation of the Slp3 protein through intricate cellular signaling mechanisms. Forskolin, by directly stimulating adenylate cyclase, increases intracellular cAMP which in turn activates PKA; this kinase phosphorylates Slp3, leading to its enhanced activity in cellular processes like vesicle trafficking. Similarly, isoproterenol, by activating beta-adrenergic receptors, elevates cAMP levels and thus promotes PKA-dependent phosphorylation of Slp3. Analogous effects are mediated by 8-Bromo-cAMP and Dibutyryl cAMP, both permeable analogs of cAMP, which perpetuate PKA activation and subsequent Slp3 phosphorylation. PMA, through PKC activation, phosphorylates Slp3, potentially increasing its activity in signaling pathways. On the other hand, Ionomycin, by elevating intracellular calcium, may activate calcineurin, leading to the dephosphorylation and activation of Slp3 in calcium-dependent pathways.
The array of activators also includes molecules that indirectly influence Slp3 activity by modulating the phosphorylation state of Slp3 or its interacting partners. Okadaic acid and Calyculin A, inhibitors of protein phosphatases PP1 and PP2A, prevent dephosphorylation of Slp3, indirectly maintaining its active phosphorylated form. Epigallocatechin gallate (EGCG), through kinase inhibition, may relieve Slp3 from negative regulatory phosphorylation events, indirectly enhancing its activity. Similarly, Sphingosine-1-phosphate activates G-protein-coupled receptors, potentially triggering PKC activation and subsequent phosphorylation of Slp3. Lastly, Anisomycin, while inhibiting protein synthesis, also activates MAPK pathways, which may phosphorylate Slp3 or modulate its function, leading to an indirect enhancement of its activity.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylate cyclase, increasing the production of cAMP. Elevated cAMP activates PKA, which can then phosphorylate Slp3, leading to its functional enhancement as part of the cAMP-dependent pathway. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent PKC activator that can phosphorylate multiple substrates, including Slp3. Activation of PKC is known to enhance the functional activity of Slp3 by promoting its association with other proteins in signaling cascades. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which can activate calcineurin. Calcineurin dephosphorylates many proteins, potentially enhancing Slp3 activity by altering its phosphorylation state. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a cell-permeable cAMP analog that activates PKA. PKA can then phosphorylate Slp3, which is likely to enhance its activity within its specific pathways, such as vesicle trafficking or membrane association. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a kinase inhibitor that may inhibit kinases that negatively regulate Slp3, thereby reducing inhibitory phosphorylation events and indirectly increasing Slp3 activity. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that increases intracellular cAMP levels, leading to the activation of PKA. PKA can phosphorylate Slp3 leading to an increase in its functional activity within signaling pathways. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases PP1 and PP2A, which may lead to an increase in the phosphorylation state of Slp3, thereby enhancing its functional activity by preventing dephosphorylation. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
db-cAMP is another cell-permeable cAMP analog that activates PKA. PKA-mediated phosphorylation of Slp3 would result in enhanced activity, promoting its role in cellular processes such as vesicle docking and secretion. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is an inhibitor of PP1 and PP2A, similar to okadaic acid, leading to increased phosphorylation of proteins. Enhanced phosphorylation leads to the activation of Slp3, as it may prevent its dephosphorylation and inactivation. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate is a bioactive lipid that activates a G-protein coupled receptor, potentially leading to PKC activation. PKC-mediated phosphorylation can enhance the activity of Slp3 in signaling pathways. | ||||||